

DIAGNOSTIC SERVICES
Next Generation Sequencing
While NGS has the power to sequence the entire human genome, our disease-focused panels are designed to target genes and fusion transcripts with clear diagnostic, therapeutic, or prognostic value. Our approach reduces unclear variants that occur in broader and non-specific NGS panels leading to more actionable results.
Turnaround time: 3-5 days
Hematology Panels
Myeloid Panel
Our comprehensive myeloid panel is a targeted NGS assay that interrogates, not only all relevant DNA mutations and insertions-deletions (up to 176 bp in length), but also fusion transcripts associated with myeloid disorders at a very high sensitivity level (3% LOD) in a single NGS run.
Diseases covered:
AML, MDS, MPN, CMML, JMML, CLL
AML Panel (19 Genes) | ||||
ASXL1 | DNMT3A | IDH2 | NPM1 | TET2 |
BRAF | FLT3 | JAK2 | NRAS | TP53 |
CBL | GATA2 | KIT | PTPN11 | WT1 |
CEBPA | IDH1 | KRAS | RUNX1 |
MDS Panel (19 Genes) | ||||
ASXL1 | EZH2 | KRAS | SETBP1 | TP53 |
DNMT3A | IDH1 | NRAS | SF3B1 | U2AF1 |
ETV6 | IDH2 | RPS14 | SRSF2 | ZRSR2 |
EVI1 | KDM6A/UTX | RUNX1 | TET2 |
MPN Panel (16 Genes) | |||
ASXL1 | EZH2 | IDH2 | SETBP1 |
CALR | JAK2 | MPL | SRSF2 |
CSF3R | JAK3 | NRAS | TET2 |
DNMT3A | IDH1 | SH2B3 | TP53 |
CMML Panel (18 Genes) | ||||
ASXL1 | EZH2 | NOTCH1 | SF3B1 | TP53 |
CBL | JAK3 | NRAS | SRSF2 | U2AF1 |
CSF3R | KRAS | RUNX1 | TET2 | ZRSR2 |
DNMT3A | MPL | SETBP1 |
CLL Panel (17 Genes) |
||||
ATM |
CD79B |
MYD88 |
PTEN |
XPO |
BTK |
DDX3X |
NOTCH1 (hotspots) |
PTPN6 |
|
BIRC3 |
FBXW7 |
PIK3CA (hotspots) |
SF3B1 |
|
CARD11 |
MAPK1 |
PIK3CD (hotspots) |
TP53 |